Glucose deprivation induces heme oxygenase-1 gene expression by a pathway independent of the unfolded protein response

被引:58
|
作者
Chang, SH
Barbosa-Tessmann, I
Chen, C
Kilberg, MS
Agarwal, A
机构
[1] Univ Florida, Div Nephrol Hypertens & Transplantat, Dept Med, Gainesville, FL 32610 USA
[2] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA
关键词
D O I
10.1074/jbc.M108921200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nutrients such as glucose regulate the expression of genes that are involved in plasma membrane transport, metabolic functions, and protein trafficking in the endoplasmic reticulum. Depletion of nutrients results in cellular stress, which evokes adaptive and protective responses, one of which is the induction of heme oxygenase-1 (HO-1), a 32-kDa endoplasmic reticulum enzyme that catalyzes the rate-limiting step in heme degradation. Incubation of HepG2 human hepatoma cells in glucose-free medium resulted in an increased HO-1 mRNA content, reaching a maximum of similar to25-fold over control cells after 12 h. The glucose-dependent induction of HO-1 mRNA was concentration-dependent (k(1/2) similar to0.5 mm) and was attenuated by fructose, galactose, mannose, and 2-deoxyglucose, but not by the non-metabolizable glucose analog, 3-O-methylglucose. Tunicamycin, thapsigargin, or azetidine 2-carboxylate, each of which activates the unfolded protein response pathway, did not induce HO-1 mRNA expression, whereas glucose-regulated protein 78 mRNA was increased. These results demonstrate that glucose availability regulates transcription of the HO-1 gene via a pathway that is different from the unfolded protein response. The induction of HO-1 may serve as a protective response in hypoglycemic circumstances and underscores the importance of understanding nutrient control of the HO-1 gene.
引用
收藏
页码:1933 / 1940
页数:8
相关论文
共 50 条
  • [1] Glucose deprivation induces heme oxygenase-1 (HO-1) gene expression by a pathway independent of the unfolded protein response
    Chang, SH
    Barbosa-Tessmann, I
    Chen, C
    Kilberg, MS
    Agarwal, A
    FASEB JOURNAL, 2002, 16 (05): : A903 - A903
  • [2] MODULATION OF INFLAMMATORY RESPONSE BY PENTOXIFYLLINE IS INDEPENDENT OF HEME OXYGENASE-1 PATHWAY
    Taha, H.
    Grochot-Przeczek, A.
    Was, H.
    Kotlinowski, J.
    Kozakowska, M.
    Marek, A.
    Skrzypek, K.
    Lackowska, B.
    Balcerczyk, A.
    Mustafa, S.
    Dulak, J.
    Jozkowicz, A.
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2009, 60 (02): : 3 - 12
  • [3] Modulation of inflammatory response by pentoxifylline is independent of heme oxygenase-1 pathway
    Taha, H.
    Grochot-Przeczek, A.
    Was, H.
    Kotlinowski, J.
    Kozakowska, M.
    Marek, A.
    Lackowska, B.
    Balcerczyk, A.
    Mustafa, S.
    Dulak, J.
    Jozkowicz, A.
    FEBS JOURNAL, 2009, 276 : 235 - 235
  • [4] Nitric oxide induces heme oxygenase-1 gene expression in mesangial cells
    Datta, PK
    Lianos, EA
    KIDNEY INTERNATIONAL, 1999, 55 (05) : 1734 - 1739
  • [5] Bortezomib induces heme oxygenase-1 expression in multiple myeloma
    Barrera, Lawrence N.
    Rushworth, Stuart A.
    Bowles, Kristian M.
    MacEwan, David J.
    CELL CYCLE, 2012, 11 (12) : 2248 - 2252
  • [6] Adrenocorticotropin induces heme oxygenase-1 expression in adrenal cells
    Pomeraniec, Y
    Grion, N
    Gadda, L
    Pannunzio, V
    Podesta, EI
    Cymeryng, CB
    JOURNAL OF ENDOCRINOLOGY, 2004, 180 (01) : 113 - 124
  • [7] Expression of Heme Oxygenase-1 in Response to Proteasomal Inhibition
    Yerlikaya, Azmi
    PROTEIN AND PEPTIDE LETTERS, 2012, 19 (12): : 1330 - 1333
  • [8] Diallyl sulfide induces heme oxygenase-1 through MAPK pathway
    Gong, PF
    Hu, B
    Cederbaum, A
    FREE RADICAL BIOLOGY AND MEDICINE, 2004, 37 : S35 - S35
  • [9] Diallyl sulfide induces heme oxygenase-1 through MAPK pathway
    Gong, PF
    Hu, B
    Cederbaum, AI
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2004, 432 (02) : 252 - 260
  • [10] Transcriptional regulation of the heme oxygenase-1 gene via the stress response element pathway
    Alam, J
    Cook, JL
    CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (30) : 2499 - 2511